We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Biosimilars Can Now Rely on Non-EEA Comparators
European Biosimilars Can Now Rely on Non-EEA Comparators
December 16, 2014
Manufacturers seeking approval of biosimilars in the EU will be able to use comparator biologics authorized outside the European Economic Area to support marketing clearance, according to final guidance set to take effect April 30.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor